158-12 | Maryland Oncology Hematology

158-12

Trial Information

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Learn More at ClinicalTrials.gov

Sponsor: Merck Sharp & Dohme LLC

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Solid Tumors

Investigator

Wallmark

Sponsor

Merck Sharp & Dohme LLC

« Clinical Trails Main

Quality Care Close to Home

View our locations on map!